Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.96
-0.19 (-1.18%)
At close: May 01, 2025, 3:59 PM
16.88
5.73%
After-hours: May 01, 2025, 05:33 PM EDT
Immunovant Revenue
Immunovant reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Immunovant generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
207
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2024 | 0 | n/a |
| Mar 31, 2023 | 0 | n/a |
| Mar 31, 2022 | 0 | n/a |
| Mar 31, 2021 | 0 | n/a |
| Mar 31, 2020 | 0 | n/a |